Qatar Chamber will organise an exhibition for food and pharmaceutical industries in co-operation with the Ministry of Energy and Industry, from September 24 to 26.
The first edition of the food and medicine ‘MedFood 2017’ expo aims at introducing national products in food and medicine and providing a platform for presenting the most important companies and factories operating in these activities, thus contributing to the achievement of food and medicine security in the State.
Qatar Chamber said at a press conference to announce this event that the exhibition aims to support the national food industries, achieve more self-sufficiency and reduce dependence on food imports.
Saleh bin Hamad al-Sharqi, Director General of Qatar Chamber, said that the exhibition reflects Qatar Chamber’s keenness to support the national food and pharmaceutical industries, increase the self-sufficiency of the local market and reduce dependence on food and pharmaceutical imports, in addition to activating the Qatari food and pharmaceutical manufacturing sectors to work towards self-sufficiency in food and medicine in the country.
He added that the exhibition will bring together a number of leading food companies and local pharmaceutical factories.
The first edition of the exhibition will be limited to local companies.
The next edition of the exhibition will be international in nature, with international companies and well-known brands taking part.
For his part, Mohamed al-Harqan, Director of Public Relations Department at the Ministry of Energy and Industry, said that the MedFood 17 exhibition seeks to develop local industries in two sectors that are of great importance to the local market.
He hoped that the first edition of the exhibition will achieve its goals. He noted the ministry’s efforts to support activities aimed at developing local industries since its participation in the first edition of the “Made in Qatar” exhibition organised by the Chamber in 2008.
The event will also highlight investments in pharmaceuticals and medical supplies, and will reveal initiatives for the private sector to achieve drug security.